🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Application of next-generation imaging in biochemically recurrent prostate cancer published in Pros Ca Pros Dis Prostate Cancer and Prostatic Diseases pubmed.ncbi.nlm.nih.gov/37679601/ Special thanks to all my coauthors for this collaborative effort! Stephen Freedland, MD Johannes Czernin

Article available until mid-October at authors.elsevier.com/a/1hgEc1Hx52GM…

Our work on AI-generated versus clinical prostate contours for ultrasound-based HDR brachytherapy is now published. Basically, observers preferred AI contours for the majority of the cases. Thank you Brigham and Women’s Radiation Oncology for your support. American Brachy doi.org/10.1002/mp.167…

Are you ready to take your practice to new heights? If so, we have an incredible opportunity that you won't want to miss! Join us for the 2023 Prostate #brachy Workshop. Learn from and collaborate with leading experts in the field. bit.ly/47pGjIV #thisisbrachytherapy

Meet our faculty for #Prostate #Brachytherapy Essentials! Join @MTKingMD Gerard Morton Juanita Crook, and Michael Folkert for Organ at Risk Constraints and Management of Toxicities. Explore cutting-edge advancements to enhance treatment outcomes. bit.ly/3zBBv74

Our manuscript on AI tumor volume for prognosticating outcomes after radiation and surgery has been published in Radiology. A big thanks to the team for getting this work out there! Brigham and Women’s Radiation Oncology David Yang Katie Lee pubs.rsna.org/doi/10.1148/ra… massgeneralbrigham.org/en/about/newsr…

🔍The volume of AI-segmented intraprostatic tumors is an independent prognostic factor for outcomes in localized prostate cancer treated with radical prostatectomy and radiation therapy. Insights from David Yang, Katie Lee, Martin King, & Brigham and Women’s Radiation Oncology! pubs.rsna.org/doi/10.1148/ra…

The volume of AI-segmented prostatic tumors was an independent prognostic factor for outcomes of localized prostate cancer treated with radical prostatectomy and radiation therapy. Brigham and Women’s Radiation Oncology David Yang @KatieLeeMDPHD Martin King bit.ly/4hnxfcw

Our article on long-term outcomes of the 44/20 and 20/0 randomized trials involving prostate brachytherapy has been published in Practical Radiation Oncology! authors.elsevier.com/a/1k5Jd6hRQmwM… American Brachy

Researchers Drs. Martin King & David Yang discuss AI's potential to automate and standardize prostate tumor assessment. Could this revolutionize clinical decision-making in #oncology? Watch the full discussion on UroToday.com - bit.ly/4fNC9O7

AI-derived tumor volume from multiparametric MRI and outcomes in localized #ProstateCancer. Martin King & David Yang Brigham and Women's Hospital join Zach Klaassen Georgia Cancer Center to discuss their work demonstrates how their AI model successfully segments and measures prostate tumors from MRI

An AI algorithm for measuring tumor volume and prostate volume on MRI can prognosticate both oncologic and toxicity outcomes, respectively, after prostate RT, specifically brachytherapy. Free link until 5/5. authors.elsevier.com/c/1kttXcA0-MJgG Radiotherapy & Oncology American Brachy